Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas De Prost

Showing results (181-190 of 192) with videos related to

Pageof 20
Sort By:
Trials|December 18, 2019
The Artificial Kidney Initiation in Kidney Injury 2 (AKIKI2): study protocol for a randomized controlled trialStéphane Gaudry, David Hajage, Laurent Martin-Lefevre, et al.
Intensive Care Medicine|October 27, 2019
Severe leptospirosis in non-tropical areas: a nationwide, multicentre, retrospective study in French ICUsArnaud-Félix Miailhe, Emmanuelle Mercier, Adel Maamar, et al.
Lancet (London, England)|April 4, 2021
Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trialStéphane Gaudry, David Hajage, Laurent Martin-Lefevre, et al.
Intensive Care Medicine|February 26, 2024
Renal replacement therapy initiation strategies in comatose patients with severe acute kidney injury: a secondary analysis of a multicenter randomized controlled trialThomas Rambaud, David Hajage, Didier Dreyfuss, et al.
Nature Communications|October 12, 2022
Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19Nicolas de Prost, Etienne Audureau, Nicholas Heming, et al.
The Journal of Experimental Medicine|December 16, 2024
A common form of dominant human IFNAR1 deficiency impairs IFN-α and -ω but not IFN-β-dependent immunityFahd Al Qureshah, Jérémie Le Pen, Nicole A de Weerd, et al.
Annals of Intensive Care|April 24, 2024
COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variantsPierre Bay, Etienne Audureau, Sébastien Préau, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Plasma exchange for severe alveolar hemorrhage in ANCA-associated vasculitis: emulation of a target trialAnne-Claire Sanna, Ségolène Gendreau, Cyrielle Desnos, et al.
The Lancet. Respiratory Medicine|November 29, 2021
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID studyJean-Pierre Gangneux, Eric Dannaoui, Arnaud Fekkar, et al.
Research Square|January 19, 2022
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodiesJeremy Manry, Paul Bastard, Adrian Gervais, et al.
Pageof 20

Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
Trials|December 18, 2019
The Artificial Kidney Initiation in Kidney Injury 2 (AKIKI2): study protocol for a randomized controlled trialStéphane Gaudry, David Hajage, Laurent Martin-Lefevre, et al.
Intensive Care Medicine|October 27, 2019
Severe leptospirosis in non-tropical areas: a nationwide, multicentre, retrospective study in French ICUsArnaud-Félix Miailhe, Emmanuelle Mercier, Adel Maamar, et al.
Lancet (London, England)|April 4, 2021
Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trialStéphane Gaudry, David Hajage, Laurent Martin-Lefevre, et al.
Intensive Care Medicine|February 26, 2024
Renal replacement therapy initiation strategies in comatose patients with severe acute kidney injury: a secondary analysis of a multicenter randomized controlled trialThomas Rambaud, David Hajage, Didier Dreyfuss, et al.
Nature Communications|October 12, 2022
Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19Nicolas de Prost, Etienne Audureau, Nicholas Heming, et al.
The Journal of Experimental Medicine|December 16, 2024
A common form of dominant human IFNAR1 deficiency impairs IFN-α and -ω but not IFN-β-dependent immunityFahd Al Qureshah, Jérémie Le Pen, Nicole A de Weerd, et al.
Annals of Intensive Care|April 24, 2024
COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variantsPierre Bay, Etienne Audureau, Sébastien Préau, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Plasma exchange for severe alveolar hemorrhage in ANCA-associated vasculitis: emulation of a target trialAnne-Claire Sanna, Ségolène Gendreau, Cyrielle Desnos, et al.
The Lancet. Respiratory Medicine|November 29, 2021
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID studyJean-Pierre Gangneux, Eric Dannaoui, Arnaud Fekkar, et al.
Research Square|January 19, 2022
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodiesJeremy Manry, Paul Bastard, Adrian Gervais, et al.
Pageof 20